Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke

Neurology

Volumn 50, Issue 4, 1998, Pages 864-870

  Tong, D C ^a,b   Yenari, M A ^a   Albers, G W ^a   O'Brien, M ^a   Marks, M P ^a   Moseley, M E ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b Stanford California and Cofounder   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; APTIGANEL; LUBELUZOLE; NALMEFENE; NEUROPROTECTIVE AGENT;

ACUTE DISEASE; AGED; ARTICLE; BRAIN ISCHEMIA; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFUSION; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0031924087     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.50.4.864     Document Type: Article

References (22)

1. Moseley ME, Mintorovitch J, Cohen Y, et al. Early detection of ischemic injury: comparison of spectroscopy, diffusion, T2-, and magnetic susceptibility-weighted MRI in cats. Acta Neurochir Suppl (Wien) 1990;51:207-209.
2. Mintorovitch J, Moseley ME, Chileuitt L, Shimizu H, Cohen Y, Weinstein PR. Comparison of diffusion- and T2-weighted MRI for the early detection of cerebral ischemia and reperfusion in rats. Magn Reson Med 1991;18:39-50.
3. Pierpaoli C, Alger JR, Righini A, et al. High temporal resolution diffusion MRI of global cerebral ischemia and reperfusion. J Cereb Blood Flow Metab 1996;16:892-905.
4. Sorensen AG, Buonanno FS, Gonzalez RG, et al. Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging. Radiology 1996;199:391-401.
5. Fisher M, Prichard JW, Warach S. New magnetic resonance techniques for acute ischemic stroke. JAMA 1995;274:908-911.
6. Muir KW, Weir CJ, Murray GD, Povey C, Lees KR. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke 1996;27:1817-1820.
7. Goldstein LB, Samsa GP. Reliability of the National Institutes of Health Stroke Scale: extension to non-neurologists in the context of a clinical trial. Stroke 1997;28:307-310.
8. Lyden P, Brott T, Tilley B, et al. Improved reliability of the NIH Stroke Scale using video training: NINDS TPA Stroke Study Group. Stroke 1994;25:2220-2226.
9. Goldstein LB, Bertels C, Davis JN. Interrater reliability of the NIH stroke scale. Arch Neurol 1989;46:660-662.
10. Brott T, Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864-870.
11. Warach S, Dashe JF, Edelman RR. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab 1996;16:53-59.
12. Lovblad KO, Baird AE, Schlaug G, et al. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol 1997;42:164-170.
13. Baird AE, Benfield A, Schlaug G, et al. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 1997;41:581-589.
14. Heiss WD, Huber M, Fink GR, et al. Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab 1992;12:193-203.
15. Baron JC, von Kummer R, del Zoppo GJ. Treatment of acute ischemic stroke: challenging the concept of a rigid and universal time window. Stroke 1995;26:2219-2221.
16. Muller TB, Haraldseth O, Jones RA, et al. Perfusion and diffusion-weighted MR imaging for in vivo evaluation of treatment with U74389G in a rat stroke model. Stroke 1995;26: 1453-1458.
17. Minematsu K, Fisher M, Li L, Sotak CH. Diffusion and perfusion magnetic resonance imaging studies to evaluate a noncompetitive N-methyl-D-aspartate antagonist and reperfusion in experimental stroke in rats. Stroke 1993;24: 2074-2081.
18. Kozniewska E, Roberts TP, Tsuura M, Mintorovitch J, Moseley ME, Kucharczyk J. NG-nitro-L-arginine delays the development of brain injury during focal ischemia in rats. Stroke 1995;26:282-288. Discussion 288-289.
19. Kucharczyk J, Mintorovitch J, Moseley ME, et al. Ischemic brain damage: reduction by sodium-calcium ion channel modulator RS-87476. Radiology 1991;179:221-227.
20. Lo EH, Pierce AR, Mandeville JB, Rosen BR. Neuroprotection with NBQX in rat focal cerebral ischemia: effects on ADC probability distribution functions and diffusion-perfusion relationships. Stroke 1997;28:439-446.
21. Yenari MA, Palmer JT, Sun GH, de Crespigny A, Moseley ME, Steinberg GK. Time-course and treatment response with SNX-111, an N-type calcium channel blocker, in a rodent model of focal cerebral ischemia using diffusion-weighted MRI. Brain Res 1996;739:36-45.
22. Warach S, Benfield A, Schlaug G, Siewert B, Edelman RR. Reduction of lesion volume in human stroke by Citicoline detected by diffusion weighted MRI: a pilot study. Ann Neurol 1996;40:527-528A.